These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

769 related items for PubMed ID: 16452232

  • 1. Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.
    Burgess T, Coxon A, Meyer S, Sun J, Rex K, Tsuruda T, Chen Q, Ho SY, Li L, Kaufman S, McDorman K, Cattley RC, Sun J, Elliott G, Zhang K, Feng X, Jia XC, Green L, Radinsky R, Kendall R.
    Cancer Res; 2006 Feb 01; 66(3):1721-9. PubMed ID: 16452232
    [Abstract] [Full Text] [Related]

  • 2. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts.
    Kim KJ, Wang L, Su YC, Gillespie GY, Salhotra A, Lal B, Laterra J.
    Clin Cancer Res; 2006 Feb 15; 12(4):1292-8. PubMed ID: 16489086
    [Abstract] [Full Text] [Related]

  • 3. A novel one-armed anti-c-Met antibody inhibits glioblastoma growth in vivo.
    Martens T, Schmidt NO, Eckerich C, Fillbrandt R, Merchant M, Schwall R, Westphal M, Lamszus K.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 1):6144-52. PubMed ID: 17062691
    [Abstract] [Full Text] [Related]

  • 4. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R.
    Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398
    [Abstract] [Full Text] [Related]

  • 5. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM.
    Cancer Res; 2005 Sep 01; 65(17):7775-81. PubMed ID: 16140945
    [Abstract] [Full Text] [Related]

  • 6. Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models.
    Cao B, Su Y, Oskarsson M, Zhao P, Kort EJ, Fisher RJ, Wang LM, Vande Woude GF.
    Proc Natl Acad Sci U S A; 2001 Jun 19; 98(13):7443-8. PubMed ID: 11416216
    [Abstract] [Full Text] [Related]

  • 7. Targeting the c-Met pathway potentiates glioblastoma responses to gamma-radiation.
    Lal B, Xia S, Abounader R, Laterra J.
    Clin Cancer Res; 2005 Jun 15; 11(12):4479-86. PubMed ID: 15958633
    [Abstract] [Full Text] [Related]

  • 8. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K, Matsumoto K, Date K, Shimura H, Tanaka M, Nakamura T.
    Cancer Res; 2000 Dec 01; 60(23):6737-43. PubMed ID: 11118060
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F, Engst S, Yamaguchi K, Yu P, Won KA, Mock L, Lou T, Tan J, Li C, Tam D, Lougheed J, Yakes FM, Bentzien F, Xu W, Zaks T, Wooster R, Greshock J, Joly AH.
    Cancer Res; 2009 Oct 15; 69(20):8009-16. PubMed ID: 19808973
    [Abstract] [Full Text] [Related]

  • 10. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines.
    Watanabe T, Tsuda M, Makino Y, Ichihara S, Sawa H, Minami A, Mochizuki N, Nagashima K, Tanaka S.
    Mol Cancer Res; 2006 Jul 15; 4(7):499-510. PubMed ID: 16849525
    [Abstract] [Full Text] [Related]

  • 11. A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells.
    Hov H, Holt RU, Rø TB, Fagerli UM, Hjorth-Hansen H, Baykov V, Christensen JG, Waage A, Sundan A, Børset M.
    Clin Cancer Res; 2004 Oct 01; 10(19):6686-94. PubMed ID: 15475459
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor.
    Date K, Matsumoto K, Kuba K, Shimura H, Tanaka M, Nakamura T.
    Oncogene; 1998 Dec 10; 17(23):3045-54. PubMed ID: 9881707
    [Abstract] [Full Text] [Related]

  • 13. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis.
    Abounader R, Lal B, Luddy C, Koe G, Davidson B, Rosen EM, Laterra J.
    FASEB J; 2002 Jan 10; 16(1):108-10. PubMed ID: 11729097
    [Abstract] [Full Text] [Related]

  • 14. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.
    Maulik G, Kijima T, Ma PC, Ghosh SK, Lin J, Shapiro GI, Schaefer E, Tibaldi E, Johnson BE, Salgia R.
    Clin Cancer Res; 2002 Feb 10; 8(2):620-7. PubMed ID: 11839685
    [Abstract] [Full Text] [Related]

  • 15. Noncompetitive inhibition of hepatocyte growth factor-dependent Met signaling by a phage-derived peptide.
    Tam EM, Runyon ST, Santell L, Quan C, Yao X, Kirchhofer D, Skelton NJ, Lazarus RA.
    J Mol Biol; 2009 Jan 09; 385(1):79-90. PubMed ID: 18973760
    [Abstract] [Full Text] [Related]

  • 16. Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4.
    Heideman DA, van Beusechem VW, Bloemena E, Snijders PJ, Craanen ME, Offerhaus GJ, Derksen PW, de Bruin M, Witlox MA, Molenaar B, Meijer CJ, Gerritsen WR.
    J Gene Med; 2004 Mar 09; 6(3):317-27. PubMed ID: 15026993
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model.
    Tomioka D, Maehara N, Kuba K, Mizumoto K, Tanaka M, Matsumoto K, Nakamura T.
    Cancer Res; 2001 Oct 15; 61(20):7518-24. PubMed ID: 11606388
    [Abstract] [Full Text] [Related]

  • 18. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
    Tiran Z, Oren A, Hermesh C, Rotman G, Levine Z, Amitai H, Handelsman T, Beiman M, Chen A, Landesman-Milo D, Dassa L, Peres Y, Koifman C, Glezer S, Vidal-Finkelstein R, Bahat K, Pergam T, Israel C, Horev J, Tsarfaty I, Ayalon-Soffer M.
    Clin Cancer Res; 2008 Jul 15; 14(14):4612-21. PubMed ID: 18628476
    [Abstract] [Full Text] [Related]

  • 19. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ, Chen WK, Wang CJ, Lin WL, Tseng TH.
    Toxicol Appl Pharmacol; 2008 Jan 15; 226(2):178-91. PubMed ID: 17961621
    [Abstract] [Full Text] [Related]

  • 20. A novel rabbit anti-hepatocyte growth factor monoclonal neutralizing antibody inhibits tumor growth in prostate cancer cells and mouse xenografts.
    Yu Y, Chen Y, Ding G, Wang M, Wu H, Xu L, Rui X, Zhang Z.
    Biochem Biophys Res Commun; 2015 Aug 14; 464(1):154-60. PubMed ID: 26093299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.